New hope for tiniest Babies' lungs: testing a Late-Stage treatment
NCT ID NCT06855043
Summary
This study is testing the safety and initial effects of a late surfactant treatment combined with budesonide for extremely premature infants who are still on a breathing machine at 7-14 days old. The goal is to see if this approach can help prevent a serious, chronic lung condition called bronchopulmonary dysplasia (BPD). Researchers will closely monitor 24 infants for immediate safety and changes in their breathing support needs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE MECHANICAL VENTILATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
American Family Children's Hospital
Madison, Wisconsin, 53792, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Meriter Hospital
Madison, Wisconsin, 53715, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.